marketcaparena
Search

    GDRX

    GoodRx Holdings, Inc.

    Company overview

    Market capitalization
    —
    Employees
    697
    Latest publication
    2026-09-29
    About GoodRx Holdings, Inc.

    GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USD
    Total Revenue194,006,000USD194,785,000USD196,028,000USD203,070,000USD202,970,000USD198,583,000USD200,610,000USD197,880,000USD
    Cost Of Revenue41,948,000USD17,464,000USD13,419,000USD33,079,000USD13,364,000USD12,193,000USD11,870,000USD12,468,000USD
    Gross Profit152,058,000USD177,321,000USD182,609,000USD169,991,000USD189,606,000USD186,390,000USD188,740,000USD185,412,000USD
    Research Development30,177,000USD28,939,000USD31,012,000USD29,933,000USD31,142,000USD31,739,000USD30,854,000USD31,017,000USD
    Selling General Administrative26,819,000USD23,937,000USD32,014,000USD28,379,000USD29,630,000USD23,546,000USD27,589,000USD41,108,000USD
    Unclassified Operating Expenses75,515,000USD23,146,000USD21,431,000USD—20,912,000USD19,096,000USD16,965,000USD15,942,000USD
    Total Operating Expenses132,511,000USD154,638,000USD167,989,000USD142,281,000USD166,226,000USD168,210,000USD168,862,000USD178,031,000USD
    Operating Income19,547,000USD22,683,000USD14,620,000USD27,710,000USD23,380,000USD18,180,000USD19,878,000USD7,381,000USD
    Interest Income1,397,000USD1,889,000USD2,309,000USD2,803,000USD3,932,000USD4,587,000USD6,334,000USD7,555,000USD
    Interest Expense9,767,000USD10,403,000USD10,829,000USD10,729,000USD10,644,000USD11,358,000USD14,566,000USD14,643,000USD
    Net Interest Income-8,370,000USD-8,514,000USD-8,520,000USD-7,926,000USD-6,712,000USD-6,771,000USD-8,232,000USD-7,088,000USD
    Income Before Tax5,639,000USD14,193,000USD6,100,000USD19,577,000USD16,668,000USD11,409,000USD11,646,000USD293,000USD
    Income Tax Expense4,470,000USD8,768,000USD4,981,000USD6,734,000USD5,616,000USD4,669,000USD4,952,000USD1,302,000USD
    Tax Provision4,470,000USD8,768,000USD4,981,000USD6,734,000USD5,616,000USD4,669,000USD4,952,000USD1,302,000USD
    Net Income1,169,000USD5,425,000USD1,119,000USD12,843,000USD11,052,000USD6,740,000USD6,694,000USD-1,009,000USD
    Net Income From Continuing Ops1,169,000USD5,425,000USD1,119,000USD12,843,000USD11,052,000USD6,740,000USD6,694,000USD-1,009,000USD
    Ebit15,406,000USD24,596,000USD16,929,000USD30,306,000USD27,312,000USD22,767,000USD26,212,000USD14,936,000USD
    Ebitda37,198,000USD47,742,000USD38,360,000USD50,035,000USD48,224,000USD41,863,000USD43,177,000USD30,878,000USD
    Depreciation And Amortization21,792,000USD23,146,000USD21,431,000USD19,729,000USD20,912,000USD19,096,000USD16,965,000USD15,942,000USD
    Reconciled Depreciation21,792,000USD23,146,000USD21,431,000USD19,729,000USD20,912,000USD19,096,000USD16,965,000USD15,942,000USD
    Total Other Income Expense Net-13,908,000USD-8,490,000USD-8,520,000USD-8,133,000USD-6,712,000USD-6,771,000USD-8,232,000USD-7,088,000USD
    Selling And Marketing Expenses—78,616,000USD83,532,000USD84,870,000USD84,542,000USD93,829,000USD93,454,000USD89,964,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue796,853,000USD792,324,000USD766,554,000USD745,424,000USD388,224,000USD249,522,000USD
    Cost Of Revenue57,597,000USD48,215,000USD65,079,000USD46,716,000USD14,016,000USD6,035,000USD
    Gross Profit739,256,000USD744,109,000USD701,475,000USD698,708,000USD374,208,000USD243,487,000USD
    Research Development121,026,000USD123,749,000USD143,137,000USD125,860,000USD29,300,000USD43,894,000USD
    Selling General Administrative113,960,000USD117,862,000USD144,792,000USD154,686,000USD14,692,000USD8,359,000USD
    Selling And Marketing Expenses331,560,000USD367,114,000USD357,631,000USD370,217,000USD176,967,000USD104,177,000USD
    Unclassified Operating Expenses85,218,000USD69,538,000USD54,177,000USD34,539,000USD13,573,000USD9,806,000USD
    Total Operating Expenses651,764,000USD678,263,000USD699,737,000USD685,302,000USD234,532,000USD166,236,000USD
    Operating Income87,492,000USD65,846,000USD1,738,000USD13,406,000USD139,676,000USD77,251,000USD
    Interest Income10,933,000USD23,273,000USD9,274,000USD59,000USD715,000USD154,000USD
    Interest Expense42,605,000USD52,922,000USD34,243,000USD23,642,000USD49,569,000USD22,193,000USD
    Net Interest Income-31,672,000USD-29,649,000USD-24,969,000USD-23,583,000USD-48,854,000USD-22,039,000USD
    Income Before Tax56,538,000USD31,460,000USD-23,231,000USD-10,177,000USD82,978,000USD52,348,000USD
    Income Tax Expense26,099,000USD15,070,000USD9,597,000USD15,077,000USD16,930,000USD8,555,000USD
    Tax Provision26,099,000USD15,070,000USD9,597,000USD15,077,000USD16,930,000USD8,555,000USD
    Net Income30,439,000USD16,390,000USD-32,828,000USD-25,254,000USD66,048,000USD43,793,000USD
    Net Income From Continuing Ops30,439,000USD16,390,000USD-32,828,000USD-25,254,000USD66,048,000USD43,793,000USD
    Ebit99,143,000USD84,382,000USD11,012,000USD13,465,000USD132,547,000USD74,541,000USD
    Ebitda184,361,000USD153,920,000USD65,189,000USD48,004,000USD146,120,000USD84,347,000USD
    Depreciation And Amortization85,218,000USD69,538,000USD54,177,000USD34,539,000USD13,573,000USD9,806,000USD
    Reconciled Depreciation85,218,000USD69,538,000USD54,177,000USD34,539,000USD13,573,000USD9,806,000USD
    Total Other Income Expense Net-30,954,000USD-34,386,000USD-24,969,000USD-23,583,000USD-56,698,000USD-24,903,000USD
    Non Operating Income Net Other——9,274,000USD59,000USD——
    Net Income Applicable To Common Shares——-32,828,000USD-25,254,000USD42,441,000USD13,795,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Assets2,021,251,000USD1,404,058,000USD1,325,507,000USD1,318,706,000USD1,295,271,000USD1,388,067,000USD1,354,846,000USD1,475,390,000USD
    Intangible Assets201,358,000USD203,343,000USD204,891,000USD203,853,000USD198,935,000USD176,883,000USD173,959,000USD167,796,000USD
    Other Current Assets786,137,000USD126,413,000USD75,071,000USD66,990,000USD67,210,000USD50,075,000USD43,408,000USD36,074,000USD
    Total Liab1,399,265,000USD787,796,000USD724,795,000USD675,675,000USD640,924,000USD663,409,000USD658,412,000USD805,991,000USD
    Total Stockholder Equity621,986,000USD616,262,000USD600,712,000USD643,031,000USD654,347,000USD724,658,000USD696,434,000USD669,399,000USD
    Other Current Liab826,069,000USD210,139,000USD137,090,000USD77,727,000USD64,503,000USD91,637,000USD86,349,000USD67,184,000USD
    Common Stock34,000USD34,000USD34,000USD35,000USD36,000USD38,000USD38,000USD38,000USD
    Capital Stock34,000USD34,000USD34,000USD35,000USD36,000USD38,000USD38,000USD38,000USD
    Retained Earnings-1,409,405,000USD-1,410,574,000USD-1,415,999,000USD-1,417,118,000USD-1,429,961,000USD-1,441,013,000USD-1,447,753,000USD-1,451,718,000USD
    Good Will430,331,000USD430,331,000USD421,719,000USD421,719,000USD421,719,000USD410,769,000USD410,769,000USD410,769,000USD
    Cash235,710,000USD261,820,000USD273,529,000USD281,318,000USD300,981,000USD448,346,000USD423,777,000USD524,903,000USD
    Cash And Short Term Investments235,710,000USD261,820,000USD273,529,000USD281,318,000USD300,981,000USD448,346,000USD423,777,000USD524,903,000USD
    Total Current Assets1,266,468,000USD643,102,000USD565,515,000USD550,614,000USD540,208,000USD659,255,000USD626,800,000USD750,555,000USD
    Total Current Liabilities859,198,000USD246,002,000USD181,858,000USD130,909,000USD103,383,000USD123,903,000USD114,361,000USD102,473,000USD
    Current Deferred Revenue8,628,000USD6,705,000USD6,282,000USD6,076,000USD6,307,000USD6,036,000USD6,328,000USD5,988,000USD
    Net Debt305,641,000USD280,986,000USD271,606,000USD266,220,000USD240,208,000USD95,041,000USD120,790,000USD182,478,000USD
    Short Term Debt9,976,000USD9,753,000USD9,761,000USD9,821,000USD10,558,000USD10,636,000USD9,293,000USD12,417,000USD
    Short Long Term Debt5,000,000USD5,000,000USD5,000,000USD5,000,000USD5,000,000USD5,000,000USD3,750,000USD7,029,000USD
    Short Long Term Debt Total541,351,000USD542,806,000USD545,135,000USD547,538,000USD541,189,000USD543,387,000USD544,567,000USD707,381,000USD
    Long Term Debt482,422,000USD483,264,000USD484,114,000USD484,972,000USD485,837,000USD486,711,000USD487,593,000USD645,648,000USD
    Net Receivables244,621,000USD254,869,000USD216,915,000USD202,306,000USD172,017,000USD160,834,000USD159,615,000USD189,578,000USD
    Accounts Payable14,525,000USD19,405,000USD28,725,000USD25,411,000USD15,258,000USD14,137,000USD12,391,000USD16,884,000USD
    Property Plant Equipment Net40,490,000USD41,076,000USD40,970,000USD41,424,000USD34,410,000USD40,458,000USD42,467,000USD44,388,000USD
    Property Plant Equipment Gross40,490,000USD63,365,000USD40,970,000USD41,424,000USD34,410,000USD58,688,000USD42,467,000USD44,388,000USD
    Common Stock Shares Outstanding341,424,000shares340,761,000shares347,810,000shares357,159,000shares379,656,000shares383,576,000shares388,504,000shares384,732,000shares
    Non Current Assets Total754,783,000USD760,956,000USD759,992,000USD768,092,000USD755,063,000USD728,812,000USD728,046,000USD724,835,000USD
    Non Current Liabilities Total540,067,000USD541,794,000USD542,937,000USD544,766,000USD537,541,000USD539,506,000USD544,051,000USD703,518,000USD
    Non Current Liabilities Other8,692,000USD8,741,000USD7,563,000USD7,049,000USD6,910,000USD6,755,000USD8,777,000USD8,554,000USD
    Non Currrent Assets Other29,562,000USD29,095,000USD23,319,000USD23,914,000USD22,817,000USD23,520,000USD34,941,000USD36,614,000USD
    Net Working Capital407,270,000USD397,100,000USD383,657,000USD419,705,000USD436,825,000USD535,352,000USD512,439,000USD648,082,000USD
    Unclassified Non Current Assets53,042,000USD57,111,000USD69,093,000USD77,182,000USD77,182,000USD77,182,000USD65,910,000USD65,268,000USD
    Unclassified Non Current Liabilities48,953,000USD49,789,000USD51,260,000USD52,745,000USD44,794,000USD46,040,000USD47,681,000USD49,316,000USD
    Unclassified Equity2,031,323,000USD2,026,768,000USD2,016,643,000USD2,060,079,000USD2,084,236,000USD2,165,595,000USD2,144,111,000USD2,121,041,000USD
    Unclassified Current Liabilities—-5,000,000USD-5,000,000USD6,874,000USD1,757,000USD-3,543,000USD-3,750,000USD-7,029,000USD
    Accumulated Other Comprehensive Income——0USD————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets1,404,058,000USD1,388,067,000USD1,588,800,000USD1,604,631,000USD1,607,625,000USD1,470,114,000USD386,796,000USD314,791,000USD
    Intangible Assets203,343,000USD176,883,000USD156,337,000USD189,937,000USD133,777,999USD56,719,000USD26,445,000USD18,270,000USD
    Other Current Assets126,413,000USD50,075,000USD40,449,000USD40,856,000USD21,307,000USD20,384,000USD5,014,000USD3,448,000USD
    Total Liab787,796,000USD663,409,000USD826,842,000USD789,804,000USD775,945,000USD758,755,000USD1,474,378,000USD1,477,218,000USD
    Total Stockholder Equity616,262,000USD724,658,000USD761,958,000USD814,827,000USD831,680,000USD711,359,000USD-1,087,582,000USD-1,162,427,000USD
    Other Current Liab210,139,000USD91,637,000USD64,224,000USD39,644,000USD43,863,000USD30,840,000USD10,754,000USD3,732,000USD
    Common Stock34,000USD38,000USD40,000USD40,000USD40,000USD39,000USD460,000USD451,000USD
    Capital Stock34,000USD38,000USD40,000USD40,000USD40,000USD39,000USD460,000USD451,000USD
    Retained Earnings-1,410,574,000USD-1,441,013,000USD-1,457,403,000USD-1,448,535,000USD-1,415,707,000USD-1,390,453,000USD-1,096,830,000USD-1,162,878,000USD
    Good Will430,331,000USD410,769,000USD410,769,000USD412,117,000USD329,696,000USD261,116,000USD236,225,000USD220,420,000USD
    Cash261,820,000USD448,346,000USD672,296,000USD757,165,000USD941,109,000USD968,691,000USD26,050,000USD34,600,000USD
    Cash And Short Term Investments261,820,000USD448,346,000USD672,296,000USD757,165,000USD941,109,000USD968,691,000USD26,050,000USD34,600,000USD
    Total Current Assets643,102,000USD659,255,000USD872,790,000USD919,686,000USD1,088,827,000USD1,086,368,000USD86,582,000USD73,071,000USD
    Total Current Liabilities246,002,000USD123,903,000USD122,559,000USD76,320,000USD81,113,000USD59,551,000USD33,373,000USD16,620,000USD
    Current Deferred Revenue6,705,000USD6,036,000USD7,105,000USD7,879,000USD6,869,000USD6,852,000USD3,453,000USD258,000USD
    Net Debt280,986,000USD95,041,000USD38,774,000USD-40,141,000USD-238,779,000USD-263,768,000USD684,938,000USD687,636,000USD
    Short Term Debt9,753,000USD10,636,000USD14,964,000USD11,097,000USD12,880,000USD11,568,000USD9,966,000USD5,430,000USD
    Short Long Term Debt5,000,000USD5,000,000USD8,787,000USD7,029,000USD7,029,000USD7,029,000USD7,029,000USD5,430,000USD
    Short Long Term Debt Total542,806,000USD543,387,000USD711,070,000USD717,024,000USD702,330,000USD704,923,000USD710,988,000USD722,236,000USD
    Long Term Debt483,264,000USD486,711,000USD647,703,000USD651,796,000USD655,858,000USD659,888,000USD663,893,000USD716,806,000USD
    Net Receivables254,869,000USD160,834,000USD160,045,000USD121,665,000USD126,411,000USD97,293,000USD55,518,000USD35,023,000USD
    Accounts Payable19,405,000USD14,137,000USD36,266,000USD17,700,000USD17,501,000USD10,291,000USD7,851,000USD7,200,000USD
    Property Plant Equipment Net41,076,000USD40,458,000USD45,861,000USD55,726,000USD49,317,000USD50,769,000USD34,175,000USD988,000USD
    Property Plant Equipment Gross63,365,000USD58,688,000USD59,647,000USD19,820,000USD21,612,000USD50,769,000USD34,175,000USD988,000USD
    Common Stock Shares Outstanding356,973,000shares392,172,000shares410,315,000shares412,858,000shares409,981,000shares274,696,000shares362,603,000shares362,603,000shares
    Non Current Assets Total760,956,000USD728,812,000USD716,010,000USD684,945,000USD518,798,000USD383,746,000USD300,214,000USD241,720,000USD
    Non Current Liabilities Total541,794,000USD539,506,000USD704,283,000USD713,484,000USD694,832,000USD699,204,000USD1,441,005,000USD1,460,598,000USD
    Non Current Liabilities Other8,741,000USD6,755,000USD8,177,000USD7,557,000USD5,138,000USD5,849,000USD2,974,000USD3,327,000USD
    Non Currrent Assets Other29,095,000USD23,520,000USD37,775,000USD8,165,000USD2,007,001USD2,025,000USD1,162,000USD1,176,000USD
    Net Working Capital397,100,000USD535,352,000USD750,231,000USD843,366,000USD1,007,714,000USD1,026,817,000USD53,209,000USD56,451,000USD
    Unclassified Non Current Assets57,111,000USD77,182,000USD65,268,000USD10,835,000USD————
    Unclassified Current Liabilities-5,000,000USD-3,543,000USD-8,787,000USD-7,029,000USD-7,029,000USD-7,029,000USD-5,680,000USD-5,430,000USD
    Unclassified Non Current Liabilities49,789,000USD46,040,000USD48,403,000USD46,574,000USD28,454,000USD27,618,000USD771,164,000USD733,682,000USD
    Unclassified Equity2,026,768,000USD2,165,595,000USD2,219,281,000USD2,263,282,000USD2,247,307,000USD3,571,848,000USD745,337,000USD—
    Inventory——1USD—-8,331,000USD2,900,000USD1USD1USD
    Accumulated Other Comprehensive Income——0USD—0USD-1,470,114,000USD-737,009,000USD-554,000USD
    Other Liab———7,557,000USD5,382,000USD5,849,000USD2,974,000USD6,783,000USD
    Other Assets———8,165,000USD6,007,000USD15,142,000USD3,369,000USD2,042,000USD
    Net Tangible Assets———814,827,000USD831,680,000USD393,524,000USD-1,350,252,000USD-1,401,117,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income1,169,000USD5,425,000USD1,119,000USD12,843,000USD11,052,000USD6,740,000USD3,965,000USD6,694,000USD
    Depreciation21,792,000USD23,146,000USD21,431,000USD19,729,000USD20,912,000USD19,096,000USD17,535,000USD16,965,000USD
    Stock Based Compensation16,509,000USD17,919,000USD18,118,000USD21,415,000USD19,174,000USD20,959,000USD26,381,000USD26,590,000USD
    Other Non Cash Items2,185,000USD2,732,000USD9,552,000USD1,588,000USD6,211,000USD1,624,000USD3,541,000USD1,861,000USD
    Change To Account Receivables3,025,000USD-30,212,000USD-14,711,000USD-28,910,000USD-14,183,000USD-15,131,000USD30,971,000USD-17,005,000USD
    Change In Working Capital-33,886,000USD-28,316,000USD25,803,000USD-5,995,000USD-47,936,000USD7,596,000USD36,082,000USD-42,409,000USD
    Total Cash From Operating Activities11,838,000USD32,888,000USD76,023,000USD49,580,000USD9,413,000USD44,743,000USD86,862,000USD9,701,000USD
    Capital Expenditures-1,136,000USD-15,830,000USD-17,999,000USD-18,315,000USD-21,876,000USD-16,644,000USD-403,000USD-17,229,000USD
    Free Cash Flow10,702,000USD17,058,000USD58,024,000USD31,265,000USD-12,463,000USD28,099,000USD86,459,000USD-7,528,000USD
    Total Cashflows From Investing Activities-21,644,000USD-31,770,000USD-17,999,000USD-18,315,000USD-51,876,000USD-16,644,000USD-15,859,000USD-17,229,000USD
    Net Borrowings-1,250,000USD-1,250,000USD-1,250,000USD-1,250,000USD-1,250,000USD0USD-161,732,000USD—
    Total Cash From Financing Activities-16,303,999USD-12,827,000USD-65,813,000USD-50,928,000USD-104,902,000USD-3,530,000USD-172,129,000USD-864,000USD
    Sale Purchase Of Stock-12,567,000USD-9,430,000USD-61,054,000USD-45,991,000USD-99,897,000USD-188,000USD-5,431,000USD-9,152,000USD
    Change In Cash-26,110,000USD-11,709,000USD-7,789,000USD-19,663,000USD-147,365,000USD24,569,000USD-101,126,000USD-8,392,000USD
    Begin Period Cash Flow261,820,000USD273,529,000USD281,318,000USD300,981,000USD448,346,000USD423,777,000USD524,903,000USD533,295,000USD
    End Period Cash Flow235,710,000USD261,820,000USD273,529,000USD281,318,000USD300,981,000USD448,346,000USD423,777,000USD524,903,000USD
    Other Cashflows From Investing Activities-20,508,000USD-17,089,000USD-16,251,000USD-17,925,000USD-21,734,000USD-16,482,000USD-15,456,000USD-16,961,000USD
    Other Cashflows From Financing Activities-2,581,999USD-2,595,000USD-3,567,000USD-3,687,000USD-3,755,000USD-3,342,000USD-8,956,000USD893,000USD
    Unclassified Operating Cash Flow4,069,000USD11,982,000USD———-11,272,000USD——
    Unclassified Investing Cash Flow—1,149,000USD34,250,000USD36,240,000USD43,610,000USD33,126,000USD15,859,000USD34,190,000USD
    Investments——-17,999,000USD-18,315,000USD-51,876,000USD-16,644,000USD-15,859,000USD-17,229,000USD
    Unclassified Financing Cash Flow——————3,990,000USD7,395,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income30,439,000USD16,390,000USD-8,868,000USD-32,828,000USD-25,254,000USD-293,623,000USD66,048,000USD43,793,000USD
    Depreciation85,218,000USD69,538,000USD111,772,000USD54,177,000USD34,539,000USD18,430,000USD13,573,000USD9,806,000USD
    Stock Based Compensation76,626,000USD99,026,000USD104,820,000USD120,234,000USD160,462,000USD397,285,000USD3,747,000USD1,762,000USD
    Other Non Cash Items11,994,000USD8,758,000USD18,066,000USD25,984,000USD7,977,000USD52,618,000USD10,408,000USD4,096,000USD
    Change To Account Receivables-88,016,000USD-2,326,000USD-26,467,000USD1,375,000USD-43,949,000USD-16,139,000USD-14,517,000USD-12,843,000USD
    Change In Working Capital-56,444,000USD2,094,000USD-21,936,000USD-20,290,000USD-11,796,000USD-32,459,000USD-4,816,000USD-11,771,000USD
    Total Cash From Operating Activities167,904,000USD183,892,000USD138,292,000USD146,780,000USD178,779,000USD131,341,000USD83,286,000USD45,253,000USD
    Capital Expenditures-3,521,000USD-70,347,000USD-55,766,000USD-55,214,000USD-34,457,000USD-35,824,000USD-5,749,000USD-3,458,000USD
    Free Cash Flow164,383,000USD113,545,000USD82,526,000USD91,566,000USD144,322,000USD95,517,000USD77,537,000USD41,795,000USD
    Total Cashflows From Investing Activities-119,960,000USD-70,347,000USD-55,766,000USD-210,498,000USD-178,733,000USD-91,617,000USD-37,055,000USD-3,458,000USD
    Net Borrowings-5,000,000USD-167,005,000USD-5,271,000USD-7,029,000USD-7,029,000USD-7,029,000USD-57,232,000USD606,876,000USD
    Total Cash From Financing Activities-234,470,000USD-337,495,000USD-167,395,000USD-120,226,000USD-30,528,000USD905,817,000USD-54,781,000USD-24,734,000USD
    Sale Purchase Of Stock-206,942,000USD-158,845,000USD-103,974,000USD-101,721,000USD-57,688,000USD-78,714,000USD——
    Change In Cash-186,526,000USD-223,950,000USD-84,869,000USD-183,944,000USD-30,482,000USD945,541,000USD-8,550,000USD17,061,000USD
    Begin Period Cash Flow448,346,000USD672,296,000USD757,165,000USD941,109,000USD971,591,000USD26,050,000USD34,600,000USD17,539,000USD
    End Period Cash Flow261,820,000USD448,346,000USD672,296,000USD757,165,000USD941,109,000USD971,591,000USD26,050,000USD34,600,000USD
    Other Cashflows From Investing Activities-87,680,000USD-70,347,000USD-54,723,000USD-51,247,000USD-29,886,000USD-15,271,000USD-4,324,000USD-2,654,000USD
    Other Cashflows From Financing Activities-23,778,000USD-11,645,000USD-58,150,000USD-11,476,000USD-23,499,000USD-78,947,000USD828,000USD1,451,754,000USD
    Unclassified Operating Cash Flow20,071,000USD-11,914,000USD-65,562,000USD—12,851,000USD-10,910,000USD-5,674,000USD-2,433,000USD
    Unclassified Investing Cash Flow-28,759,000USD140,694,000USD96,331,000USD106,461,000USD64,343,000USD51,095,000USD10,073,000USD6,112,000USD
    Investments—-70,347,000USD-41,608,000USD-210,498,000USD-178,733,000USD-91,617,000USD-37,055,000USD-3,458,000USD
    Dividends Paid——-1USD—-22,667,000USD-78,714,000USD0USD-1,346,355,000USD
    Change To Liabilities———-4,017,000USD17,497,000USD2,154,000USD515,000USD665,000USD
    Issuance Of Capital Stock———0USD0USD991,793,000USD1,623,000USD737,009,000USD
    Cash And Cash Equivalents Changes———-183,944,000USD-30,482,000USD945,541,000USD——
    Unclassified Financing Cash Flow————80,355,000USD1,149,221,000USD—-1,474,018,000USD
    Change To Inventory—————-21,349,000USD9,018,000USD-2,550,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31ProductOther Revenue3,691,000USD0001809519-26-000111
    Q1 2026Quarterly · 2026-03-31ProductPharma Manufacturer Solutions Revenues52,230,000USD0001809519-26-000111
    Q1 2026Quarterly · 2026-03-31ProductPrescription Transactions Revenue113,692,000USD0001809519-26-000111
    Q1 2026Quarterly · 2026-03-31ProductSubscription Revenue24,393,000USD0001809519-26-000111
    FY 2025Yearly · 2025-12-31ProductOther Revenue17,686,000USD0001809519-26-000031
    FY 2025Yearly · 2025-12-31ProductPharma Direct Revenue151,380,000USD0001809519-26-000031
    FY 2025Yearly · 2025-12-31ProductPrescription Transactions Revenue544,001,000USD0001809519-26-000031
    FY 2025Yearly · 2025-12-31ProductSubscription Revenue83,786,000USD0001809519-26-000031
    Q3 2025Quarterly · 2025-09-30ProductOther Revenue4,638,000USD0001809519-25-000143
    Q3 2025Quarterly · 2025-09-30ProductPharma Manufacturer Solutions Revenues43,372,000USD0001809519-25-000143
    Q3 2025Quarterly · 2025-09-30ProductPrescription Transactions Revenue127,294,000USD0001809519-25-000143
    Q3 2025Quarterly · 2025-09-30ProductSubscription Revenue20,724,000USD0001809519-25-000143
    Q2 2025Quarterly · 2025-06-30ProductOther Revenue4,562,000USD0001809519-25-000117
    Q2 2025Quarterly · 2025-06-30ProductPharma Manufacturer Solutions Revenues34,981,000USD0001809519-25-000117
    Q2 2025Quarterly · 2025-06-30ProductPrescription Transactions Revenue143,064,000USD0001809519-25-000117
    Q2 2025Quarterly · 2025-06-30ProductSubscription Revenue20,463,000USD0001809519-25-000117
    Q1 2025Quarterly · 2025-03-31ProductOther Revenue4,382,000USD0001809519-26-000111
    Q1 2025Quarterly · 2025-03-31ProductPharma Manufacturer Solutions Revenues28,648,000USD0001809519-26-000111
    Q1 2025Quarterly · 2025-03-31ProductPrescription Transactions Revenue148,923,000USD0001809519-26-000111
    Q1 2025Quarterly · 2025-03-31ProductSubscription Revenue21,017,000USD0001809519-26-000111
    Q4 2024Quarterly · 2024-12-31ProductOther Revenue4,832,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductPharma Manufacturer Solutions Revenues28,088,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductPrescription Transactions Revenue144,987,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductSubscription Revenue20,676,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductOther Revenue21,002,000USD0001809519-26-000031
    FY 2024Yearly · 2024-12-31ProductPharma Direct Revenue107,237,000USD0001809519-26-000031
    FY 2024Yearly · 2024-12-31ProductPrescription Transactions Revenue577,549,000USD0001809519-26-000031
    FY 2024Yearly · 2024-12-31ProductSubscription Revenue86,536,000USD0001809519-26-000031
    Q3 2024Quarterly · 2024-09-30ProductOther Revenue5,390,000USD0001809519-25-000143
    Q3 2024Quarterly · 2024-09-30ProductPharma Manufacturer Solutions Revenues28,136,000USD0001809519-25-000143
    Q3 2024Quarterly · 2024-09-30ProductPrescription Transactions Revenue140,419,000USD0001809519-25-000143
    Q3 2024Quarterly · 2024-09-30ProductSubscription Revenue21,306,000USD0001809519-25-000143
    Q2 2024Quarterly · 2024-06-30ProductOther Revenue5,405,000USD0001809519-25-000117
    Q2 2024Quarterly · 2024-06-30ProductPharma Manufacturer Solutions Revenues26,504,000USD0001809519-25-000117
    Q2 2024Quarterly · 2024-06-30ProductPrescription Transactions Revenue146,748,000USD0001809519-25-000117
    Q2 2024Quarterly · 2024-06-30ProductSubscription Revenue21,953,000USD0001809519-25-000117
    Q1 2024Quarterly · 2024-03-31ProductOther Revenue5,375,000USD0001809519-25-000075
    Q1 2024Quarterly · 2024-03-31ProductPharma Manufacturer Solutions Revenues24,509,000USD0001809519-25-000075
    Q1 2024Quarterly · 2024-03-31ProductPrescription Transactions Revenue145,395,000USD0001809519-25-000075
    Q1 2024Quarterly · 2024-03-31ProductSubscription Revenue22,601,000USD0001809519-25-000075
    FY 2023Yearly · 2023-12-31ProductOther Revenue20,052,000USD0001809519-26-000031
    FY 2023Yearly · 2023-12-31ProductPharma Direct Revenue85,065,000USD0001809519-26-000031
    FY 2023Yearly · 2023-12-31ProductPrescription Transactions Revenue550,738,000USD0001809519-26-000031
    FY 2023Yearly · 2023-12-31ProductSubscription Revenue94,410,000USD0001809519-26-000031
    FY 2022Yearly · 2022-12-31ProductOther Revenue20,426,000USD0001809519-25-000040
    FY 2022Yearly · 2022-12-31ProductPharma Manufacturer Solutions Revenues99,425,000USD0001809519-25-000040
    FY 2022Yearly · 2022-12-31ProductPrescription Transactions Revenue550,536,000USD0001809519-25-000040
    FY 2022Yearly · 2022-12-31ProductSubscription Revenue96,167,000USD0001809519-25-000040
    FY 2021Yearly · 2021-12-31ProductOther Revenue18,792,000USD0001809519-24-000032
    FY 2021Yearly · 2021-12-31ProductPharma Manufacturer Solutions Revenues73,348,000USD0001809519-24-000032
    FY 2021Yearly · 2021-12-31ProductPrescription Transactions Revenue593,359,000USD0001809519-24-000032
    FY 2021Yearly · 2021-12-31ProductSubscription Revenue59,925,000USD0001809519-24-000032
    FY 2020Yearly · 2020-12-31ProductOther Revenue12,569,000USD0000950170-23-005262
    FY 2020Yearly · 2020-12-31ProductPharma Manufacturer Solutions Revenues20,488,000USD0000950170-23-005262
    FY 2020Yearly · 2020-12-31ProductPrescription Transactions Revenue488,257,000USD0000950170-23-005262
    FY 2020Yearly · 2020-12-31ProductSubscription Revenue29,386,000USD0000950170-23-005262
    FY 2019Yearly · 2019-12-31ProductOther Revenue10,557,000USD0000950170-22-002348
    FY 2019Yearly · 2019-12-31ProductPrescription Transactions Revenue364,582,000USD0000950170-22-002348
    FY 2019Yearly · 2019-12-31ProductSubscription Revenue13,085,000USD0000950170-22-002348
    FY 2018Yearly · 2018-12-31ProductOther Revenue6,611,000USD0001564590-21-012614
    FY 2018Yearly · 2018-12-31ProductPrescription Transactions Revenue242,911,000USD0001564590-21-012614

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.